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Abstract The proline-rich region of Al-type myosin essential 
light chains functions as a spacer arm separating an actin binding 
site at the extreme N-terminus from the remainder of the protein. 
Alteration of the length of this region leaving the actin binding 
site intact results in altered actin-activated MgATPase kinetics 
when these light chains are hybridised into myosin subfragment-
1. In the case of a mutant in which the length of the proline-rich 
region was doubled, actin binding by the light chain was 
uncoupled from kinetic modulation. The implications of this 
result for information transmission in the actomyosin complex 
are discussed. 
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1. Introduction 
It has now been shown unequivocally that Al-type myosin 
essential light chains (ELC) bind actin and that this actin 
binding event is directly correlated to modulation of the actin 
activated MgATPase kinetics of the myosin motor [1]. Al-
type ELCs of vertebrate striated muscle are distinguished by 
the presence of 40 or so amino acids at the N-terminus which 
are not present in the alternative isoform - A2-type [2]. In 
vertebrate fast skeletal muscle, the two proteins result from 
differential splicing of the same mRNA transcript [3]. 
The crystal structure of myosin subfragment 1 (SI, a solu-
ble, proteolytic fragment of myosin which retains the essential 
motor properties of the intact molecule [4]) shows that the 
light chains (there are two per SI molecule: one ELC and 
one regulatory light chain, RLC) are far ( > 8 nm) from the 
site of MgATP hydrolysis and the main sites of actin binding 
which are located on the heavy chain of SI [5-7]. Neverthe-
less, events in this light chain binding domain can have pro-
found effects on the behaviour of the myosin motor. In seal-
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lop myosin, calcium ion binding by the ELC switches the 
motor on [8] and in smooth muscle myosin, phosphorylation 
of the RLC results in the switching on of the motor (reviewed 
in [9]). In both cases, a message must pass from the light chain 
to the distant motor domain. 
Although the light chains are not responsible for regulating 
myosin from striated muscle, they can modulate the kinetics 
of the motor. Al-type ELCs typically endow SI carrying this 
light chain (S1A1) with a lower apparent Km for actin and a 
lower fccat for MgATP turnover in the presence of F-actin 
than A2-type ELCs [10,11]. This suggests that Al-type 
ELCs increase the affinity of SI for actin (a result supported 
by F-actin affinity chromatography studies[12,13]) but slow 
down the molecular motor. We have recently demonstrated 
that this increase in affinity results from a direct ELC-actin 
interaction involving the first 11 residues of the human atrial 
ELC (HmAtELC, an Al-type ELC [14]) and that removal of 
these residues results not only in loss of actin binding by the 
light chain but also in loss of kinetic modulation in SI mole-
cules carrying it [1]. However, these studies did not address 
the problem of how the ELC - which is some 8 nm from the 
actin filament in models of the acto-Sl complex [6,7] - can 
contact actin. In order to explain the apparent contradiction 
between our work and the structural work, it is necessary to 
explain how this gap can be bridged. 
The remaining 30-odd residues in the extension on Al-type 
ELCs is rich in (Xxx-Pro) repeats (where Xxx represents any 
amino acid; lysine and alanine are most commonly found, 
Fig. 1). Such sequences form rigid extended structures [15-
18] and we tested the hypothesis that this sequence is respon-
sible for bridging the gap between the ELC and actin which is 
apparent from the models of acto-Sl derived from the crystal 
structures. To do this, we constructed mutants of the HmAt-
ELC (which we have previously expressed in E. colt) in which 
the length of this region was altered. The effect of these 
changes was assessed by hybridising the mutant light chains 
into rabbit skeletal SI and testing whether the MgATPase 
kinetics were S1A1- or SlA2-like. The ability of the mutants 
to bind actin - both in complex with the heavy chain and 
'free' in solution - was tested by chemical cross-linking. We 
found that a mutant with this region deleted (HmAtELCAXP) 
and one in which the length was doubled (HmAtELC2XP) 
endowed kinetics on their respective SI hybrids which were 
significantly different from the wild-type HmAtELC. The ac-
tin binding ability of both mutants is not compromised by 
altering the length of the putative spacer arm: both can be 
cross-linked to actin when in free solution. However, only 
HmAtELC2XP and the wild-type HmAtELC can cross-link 
when hybridised into SI. 
These results argue strongly for the role of the (Xxx-Pro)-
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rich region being to position the actin binding site correctly on 
the surface of actin. Fur thermore, the results from the HmAt-
ELC2XP mutan t hybrid give rise to speculation on the path-
ways of information transfer within the acto-Sl complex. 
2. Materials and methods 
2.1. Construction of plasmids carrying genes encoding mutant 
HmAtELCs 
HmAtELCAXP (consisting of residues 1-11 of the wild-type se-
quence [14] fused directly to residue 45 (Fig. 1)) was expressed from 
a DNA sequence constructed by PCR [19] amplification the wild-type 
HmAtELC cDNA (a gift from Dr Anna Starzinski-Powitz, University 
of Cologne, Germany) using a 3'-primer (5'-AAGGATCCA-
GACTCTGCTTCACCCTG-3') which complements the 3' end of 
the gene and introduces a ΒατηΐΆ site 3' to the stop codon along 
with a 5'-primer (5'-AAACATATGGCTCCCAAGAAGCCT-
GAGCCTAAGAAGGAGGCAGACTTCACTGCCG-3') which 
complements bases corresponding to amino acid residues 44-50 and 
introduces a sequence coding for the first 11 amino acids, an initiation 
(methionine) codon and an Ndel restriction site 5' to this. The identity 
of this PCR product was checked by exploiting the fact that an Ndel-
Apal restriction fragment which spans the deletion is reduced from 
150 bp in the wild type to 49 bp in the mutant. The PCR product was 
then subjected to a double restriction enzyme digest using the enzymes 
NdeVBamHI and ligated into Ndel/BamHl cut pET-llc expression 
vector [20] using standard molecular biology techniques [21]. 
HmAtELC2XP (consisting of residues 1-32 of the wild-type se-
quence followed by a repeat of residues 15-32 and the wild-type 
sequence thereafter) was constructed by cutting pET-llc with the 
wild-type HmAtELC sequence inserted between the NdeVBamHl sites 
in the vector with the restriction enzyme Bsuidl which cuts uniquely 
at nucleotide position 92 (which forms part of the codon coding for 
amino acid 30). This permits the insertion of pre-annealed, synthetic 
oligonucleotides with sequence corresponding to amino acid residues 
15-32 with ends which complement the overhanging ends resulting 
from the restriction enzyme digest (5'-TGAGCCAGCTCCAGC-
TCCAGCTCCAGCTCCTGCACCAGCCCCTGCCCCAGCTCC-3' 
and 5'-TCAGGAGCTGGGGCAGGGGCTGGTGCAGGGGCTG-
GAGCTGGAGCTGGAGCTGGC-3') into the fis«36I cut pET-llc-
HmAtELC construct. 
Both mutant sequences were verified by double stranded DNA 
sequencing [22]. 
2.2. Protein preparations 
All protein manipulations were carried out at 4°C. Actin [23] and 
chymotryptic myosin SI isoenzymes [10] were prepared according to 
published procedures. Note that chymotrypsin cuts myosin between 
the ELC and RLC binding sites on the heavy chain resulting in an SI 
that has only the ELC associated with it. The wild-type HmAtELC 
was prepared from a recombinant source. Briefly, the gene sequence 
was inserted between the Ndel and BamHI sites of the expression 
vector pET-llc [20] and E. coli BL21 (DE3) cells transformed with 
this construct were grown until Λβοο = 1.0 in NZCYM medium [21], 
then induced with 0.4 M IPTG and grown for a further 3 h. Cells 
were collected by centrifugation and lysed by sonication. The lysate 
was subjected to ammonium sulphate precipitation and the 40^60% 
fraction collected and applied to a DEAE-fast flow column (Pharma-
cia Biotech). Purified ELC was eluted with a 0-0.4 M sodium chloride 
gradient and dialysed extensively against ammonium hydrogencarbo-
nate prior to freeze-drying. Mutant ELCs were prepared in the same 
manner. The molecular mass of each protein was verified by matrix-
assisted laser desorption ionisation mass spectrometry (MALDI-MS). 
F-actin was prepared by reconstituting freeze dried G-actin in buf-
fer A (5 mM triethanolamine hydrochloride (TEA-HC1), pH 7.6, 0.2 
mM CaCl2, 0.2 mM ATP, 0.25 mM DTT) in the presence of 1 mg 
solid DTT. This solution was dialysed vigorously overnight against 
buffer A, insoluble matter removed by centrifugation at 80000Xg for 
30 min and polymerisation to F-actin initiated by the addition of 
MgCl2 (2 mM, final concentration). This method of actin polymerisa-
tion was chosen so as to minimise the ionic strength of the resulting 
solutions: kinetic differences between SI isoenzymes are more pro-
nounced (and thus more easily quantified) at lower salt concentra-
tions. 
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2.3. Discontinuous actin activated MgATPase assays 
Prior to analysis, the HmAtELC mutants were hybridised into rab-
bit skeletal S1A2 using the ammonium chloride dissociation method 
[11] as modified in [24] and the pure hybrid isolated from free light 
chains and residual S1A2 by ion exchange chromatography on SP-
Trisacryl (IBF Biotechnics, France) [25]. Pure hybrid was collected 
and concentrated by precipitation in 70% (w/v) ammonium sulphate. 
Precipitates were taken up in 5 mM TEA-HC1, pH 7.5, 0.25 mM DTT 
and dialysed against this buffer overnight. 
Assays were performed in 5 mM TEA-HC1 at 25°C as follows. SI 
hybrids were mixed with F-actin prepared as described above. SI 
concentrations varied between 0.06 and 0.16 μΜ. Reactions were in-
itiated by the addition of MgCl2 to a final concentration of 2.5 mM 
and ATP to a concentration of 2.0 mM and allowed to proceed for 10 
min after which time the reaction was stopped by the addition of 
trichloroacetic acid to a final concentration of 6.7% (w/v). The 
amount of phosphate released in this time was quantified spectropho-
tometrically [26]. Rates of phosphate release (in umol P¡ released s_1) 
were normalised by dividing by the SI concentration. These activities 
were plotted against actin concentration and the kinetic parameters 
(apparent Km for actin and k^^ for MgATP turnover) were derived by 
non-linear curve fitting to the equation activity = (fccat'tactin])/ 
(fiTm+[actin]) using the program Fig-P for Windows (Biosoft, Cam-
bridge, UK). All points were weighted equally. 
2.4. Cross-linking 
Cross-linking was carried out using the zero-length cross-linker 
EDC. Proteins were mixed in the concentration ratios indicated below 
and incubated at room temperature prior to cross-linking. Protein 
concentrations ranged between 10 and 40 μΜ. EDC was then added 
to a final concentration of 66 mM and the reaction mixture left for a 
further 1 h before addition of 2% (w/v) SDS and 5% (v/v) ß-mercap-
toethanol to terminate the reaction before analysis by SDS-PAGE. 
Bands were identified by reference to molecular mass standards and 
the work of others (e.g. [29-31]). 
2.5. Analytical methods 
SDS-PAGE analysis was performed using 12% slab gels run in 0.1 
M Tris-Bicine, 0.1% (w/v) SDS at 50 mA (constant current) [27]. 
Bands were visualised by staining with Coomassie blue. MALDI-
MS [28] was carried out by Mr. P. Ashton, School of Chemistry, 
The University of Birmingham, UK. Concentrations were estimated 
by UV spectroscopy using the following values: ^280,i mg/mi (Sl) = 
0.80 m g - 1 ml; Λ280,ι mg/mi (ELC) = 0.22 m g
- 1 ml; Λ290,ι mg/mi (ac-
tin) =0.63 mg - 1 ml and molecular masses: HmAtELC, 21 kDa; 
HmAtELCAXP, 18 kDa; HmAtELC2XP, 24 kDa; actin, 42 kDa. 
3. Results 
3.1. Kinetic assays show that neither mutant behaves like the 
wild type 
The results of steady-state kinetic analysis of bo th mutan t 
hybrids are shown in Fig. 2 and the kinetic constants derived 
from this analysis are listed in Table 1. The kinetic parameters 
for rabbit skeletal S1A1 and S1A2 and the SI (HmAtELC) 
hybrid under the same conditions are also given. The SI 
(HmAtELCAXP) hybrid clearly has A2-like kinetics, showing 
that the actin binding site, al though intact, is unable to influ-
ence the myosin motor . The results with the SI (HmAt-
ELC2XP) hybrid are more interesting. The hybrid shows a 
high (i.e. SlA2-like) k^t bu t a low (i.e. SlAl- l ike) apparent 
Km for actin, suggesting that this hybrid interacts with actin 
with similar affinity to the wild-type hybrid, yet it turns 
M g A T P over a t an SlA2-like rate. 
3.2. The actin binding site of both mutant light chains is 
functional 
It was important to ascertain that changing the length of 
the (Xxx-Pro)-rich region, while leaving the actin binding site, 
intact does no t affect the functionality of this site. The wild-
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1 11 31 46 
HmAtELC MAPKKPEPKK EAAKPAPAPA PAPAPAPAPA PE APKEPAFDPK SVKIDFTA 
HmAtELCAXP MAPKKPEPKK EA DFTA 
HmAtELC2XP MAPKKPEPKK EAAKPAPAPA PAPAPAPAPA PEPAPAPAPA PAPAPAPAPE APKEPAFDPK SVKIDFTA 
50 99 
HmAtELC DQIEEFKEAF SLFDRTPTGE MKITYGQCGD VLRALGQNPT NAEVLRVLGK 
HmAtELCAXP DQIEEFKEAF SLFDRTPTGE MKITYGQCGD VLRALGQNPT NAEVLRVLGK 
HmAtELC2XP DQIEEFKEAF SLFDRTPTGE MKITYGQCGD VLRALGQNPT NAEVLRVLGK 
Fig. 1. Sequences of the wild-type and mutant HmAtELCs. Gaps have been introduced to maximise sequence identity. Numbering is based on 
the wild-type HmAtELC sequence [14], neglecting the N-terminal methionine residue. Only the first 99 residues are shown; the sequences are 
identical thereafter. 
type protein can be cross-linked to F-actin [1] and we tested 
the ability of both mutants to bind in the same way. Both 
clearly do (Fig. 3), showing that the actin binding site is fully 
functional and unaffected by changes occurring C-terminal to it. 
3.3. The length of the (Xxx-Pro)-rich arm controls actin 
binding by the mutants in the hybrids 
Rabbit skeletal A1-type ELC can be cross-linked to actin 
when in complex with the heavy chain [29-31], as can HmAt-
ELC in SI (HmAtELC) (Fig. 4A). However, if the (Xxx-
Pro)-rich region is responsible for positioning the actin bind-
ing site then testing for this cross-linking will be a sensitive 
probe for whether this site is correctly located in the acto-
hybrid SI complex. HmAtELCAXP in SI (HmAtELCAXP) 
cannot be cross-linked to F-actin (Fig. 4B), despite our suc-
cess in cross-linking the free mutant light chain (Section 3.2). 
Thus, we conclude that this actin binding site is too far from 
actin to interact. 
On the other hand, HmAtELC2XP in complex with rabbit 
skeletal heavy chain can be cross-linked to F-actin (Fig. 4C). 
This result is in agreement with the kinetic data on this hybrid 
which suggests that it binds to F-actin as strongly as the wild 
type does. This mutant hybrid is particularly interesting be-
cause although actin binding (as indicated by positive cross-
linking results and low apparent Km for actin) is correlated to 
modulation of A:cat in the wild type, these two activities of the 
ELC have become uncoupled in this case. 
4. Discussion 
For most sequences this would not be the natural state and 
actin binding would be accompanied by a transition from a 
folded to an extended structure by the 'bridging' sequence. 
This transition would be energetically unfavourable for not 
only would it involve the breaking of many intra-molecular 
contacts (enthalpically unfavourable) it would also require the 
imposition of greater order onto the system (entropically un-
favourable). Both these unfavourable influences on the free 
energy of binding can be overcome by having a sequence 
(such as the one found in A1-type light chains) which is elon-
gated and rigid prior to binding [15-18]: the enthalpic costs 
need never be paid and the entropic costs will already have 
been (largely) paid [32]. 
There is an alternative (but equivalent) kinetic way of ap-
proaching this problem. If the actin binding site were on a 
flexible arm, its search for its target site on actin would (to a 
first approximation) be one through three-dimensional space. 
By fixing the actin binding site on the end of a rigid arm this 
is reduced, essentially, to a two-dimensional search over a 
limited area. (In other words we would expect the principal 
benefits of having a rigid arm would be an increased associa-
tion rate constant; the dissociation rate constant should be 
relatively unaffected.) 
4.3. Pathways of communication in the actomyosin complex 
The site of interaction between the ELC and actin is some 
8 nm from the site of MgATP hydrolysis [6,33] and further-
more, the ELC and the myosin heavy chain interact with 
different actin monomers - most likely the ELC interacts 
4.1. General 
The (Xxx-Pro)-rich region of A1-type ELCs does function 
as a spacer arm in SI hybrids: reduction of its length prevents 
the actin binding site at the N-terminus of the light chain 
making contact with actin and this results in SlA2-like actin 
activated MgATPase kinetics. Increasing the length of the arm 
also affects the kinetics of the resulting hybrid. 
4.2. Why a rigid spacer arm? 
It is clear from models of acto-Sl based on the crystal 
structures [6,7] that a large gap needs to be bridged between 
the ELC and the actin filament if the two are to make contact. 
None of the residues in the N-terminal extension of the Al-
type ELC are observed in this structure [5], because of the 
enhanced segmental mobility of this region of SI [15], and it is 
entirely feasible that the 'missing' residues could bridge the 
gap. However, to do so they would have to be in an extended 
chain. 
[Actin] /μΜ 
Fig. 2. Actin activated MgATPase kinetics of the wild-type and mu-
tant hybrids. (■) SI (HmAtELC); (·) SI (HmAtELCAXP); ( A ) SI 
(HmAtELC2XP). The lines were fitted to each data set as described 
in the text. 
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Fig. 3. Cross-linking of mutant HmAtELCs in free solution to F-actin. M, molecular mass markers; lanes 1-3, HmAtELCAXP: actin 1:2, 1:1, 
2:1, respectively; lane 4, HmAtELCAXP; lanes 5-7, HmAtELC2XP:actin 1:2, 1:1, 2:1, respectively; lane 8 HmAtELC2XP; lane 9; actin. 
EDC was added in all cases. A, HmAtELCAXP; B, HmAtELCAXP-actin; C, HmAtELC2XP; D, HmAtELC2XP-actin. 
with the monomer immediately adjacent to the one the heavy 
chain contacts [31]. There are, therefore, two pathways by 
which information could be transmitted from the ELC-actin 
interaction site to the active site: one proceeding via SI and 
the other passing through the actin filament. 
The results with SI (HmAtELC2XP) hybrid favour one 
pathway over the other. In this hybrid, the ELC interacts 
with actin in a similar manner to the wild type (hence the 
SI Al-like apparent Km for actin and the success in cross-link-
ing the light chain to actin in the hybrid) and yet, the message 
fails to reach the active site. This argues against the 'through 
SI' pathway - since it is unlikely that this pathway could 
distinguish between different modes of actin binding: it would 
be an on/off switch triggered by the binding event. On the 
other hand, if the additional length of the arm means that 
the ELC contacts a monomer yet more distant from the sites 
of heavy chain contact with actin than the wild type (and this 
seems likely on account of the considerably increased length 
of the mutant arm) then it is conceivable that this message 
might 'fade out' as it travels that extra distance within the 
actin filament. 
This would suggest that information transmission in this 
system proceeds by a different pathway than in thick filament 
regulated smooth muscle myosin. Since there is no opportu-
nity for light chain-actin interaction in this system, informa-
tion must pass through the myosin molecule. Although 
smooth muscle RLC is phosphorylated near the N-terminus, 
the C-terminus appears to be most important in initiating 
information transmission to the active site [34]. The pathway 
does not require the ELC [35] suggesting that the initial stages 
Table 1 
Kinetic parameters of the mutant hybrids 
Hybrid Apparent Km for actin (μΜ) fccat (S *) 
RbSk SlAl 
RbSk S1A2 
SI (HmAtELC) 
SI (HmAtELCAXP) 
SI (HmAtELC2XP) 
4.2 ±0.6 
31.9 ±9.9 
5.4 ±1.5 
26.6 ±4.8 
5.7 ±0.7 
13.7± 1.1 
34.6 ±9.5 
15.3 ±2.8 
24.3 ± 3.8 
28.3 ±2.7 
20 
24 
32 
24 
28 
Rabbit skeletal (RbSk) SlAl and S1A2 and the wild-type HmAtELC hybrid under the same conditions are given for comparison, n, number of 
determinations. 
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Fig. 4. Cross-linking of wild-type and mutant HmAtELC hybrids to F-actin. (A) Lanes 1,2, SI (HmAtELC):actin 1:4 and 1:2, respectively; 
lane 3, SI (HmAtELC). (B) Lanes 1-3, SI (HmAtELCAXP):actin 1:4, 1:2 and 1:1, respectively; lane 4, actin; lane 5, HmAtELCAXP. (C) 
Lanes 1,2, SI (HmAtELC2XP):actin 1:4 and 1:2, respectively; lane 3, SI (HmAtELC2XP). EDC was added in all cases. 
of information transfer involve the N-terminus of the RLC, 
then the C-terminus and thereafter the myosin heavy chain. 
Clearly the acto-myosin system is a complex one - acted 
upon by many, interacting modulators. It seems likely that 
different pathways of communication are important in differ-
ent systems. While determining the röle of the proline-rich 
region of A1-type myosin essential light chains we have also 
been able to suggest what one important pathway in striated 
muscle myosin might be. Al-type myosin ELCs bind actin 
and modulate motor function; they do so by transmitting a 
message to the active site of myosin. Our results suggest that 
this message is unlikely to pass through SI and may well be 
propagated through the actin filament. The possession of a 
mutant ELC which, when hybridised into SI, results in the 
uncoupling of the actin binding and kinetic modulation func-
tions of the light chain should enable this important problem 
to be investigated further. 
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